Akanksha Thakkar (@athakkarmd) 's Twitter Profile
Akanksha Thakkar

@athakkarmd

Interventional Cardiology from @umnews ~ Cardiology from @HMHCardioFellow ~ Nature lover and all things Calvin & Hobbes ~ Here for #CardioEd

ID: 2811724484

calendar_today15-09-2014 18:09:57

157 Tweet

626 Followers

333 Following

Houston Methodist Cardiovascular Fellowships (@hmhcardiofellow) 's Twitter Profile Photo

At Houston Methodist, we are very excited to train the next generation of cardiologists & leaders in the field! Watch this 📹video & meet our team 👉bit.ly/2EloT7k Visit our page👉 bit.ly/2YncgQl Wishing all applicants the very best! #Cardiotwitter #ACCFIT

At Houston Methodist, we are very excited to train the next generation of cardiologists & leaders in the field! 

Watch this 📹video & meet our team 👉bit.ly/2EloT7k
Visit our page👉 bit.ly/2YncgQl

Wishing all applicants the very best! 
#Cardiotwitter #ACCFIT
DeBakey CV Education - World Class CV Training (@debakeycvedu) 's Twitter Profile Photo

Don’t miss #CVDprevention on Oct 3 with Khurram Nasir! Hear updates on the latest recommendations for #heartdisease #prevention, from #hearthealthy lifestyle interventions to testing and #clinical decision making. #CardioEd #CardioTwitter Sign up: bit.ly/2V9J79N

Don’t miss #CVDprevention on Oct 3 with 
<a href="/khurramn1/">Khurram Nasir</a>! Hear updates on the latest recommendations for #heartdisease #prevention, from #hearthealthy lifestyle interventions to testing and #clinical decision making. #CardioEd #CardioTwitter

Sign up: bit.ly/2V9J79N
Javier Torres (@jtllergo) 's Twitter Profile Photo

EMPEROR reduced: Empagliflozine ‼️ ⬇️ 25% CV death or HHF (regardless of the presence or absence of diabetes) ‼️⬇️ 30% HHF ‼️Annual rate of decline in GFR rate was slower (–0.55 vs. –2.28 ml per minute) nejm.org/doi/full/10.10… #ESCCongress Soc Esp Cardiología

EMPEROR reduced: Empagliflozine
‼️ ⬇️ 25% CV death or HHF (regardless of the presence or absence of diabetes)
‼️⬇️ 30% HHF 
‼️Annual rate of decline in GFR rate was slower (–0.55 vs. –2.28 ml per minute)
nejm.org/doi/full/10.10…
#ESCCongress <a href="/secardiologia/">Soc Esp Cardiología</a>
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@drmarthagulati) 's Twitter Profile Photo

#ESCCongress #EVAPORATE result being presented now! Matthew Budoff MD ♥️Study designed to look at effect of EPA on plaque progression using CTA at baseline/9m/18m vs placebo ♥️Small study size but powered to assess endpoint ♥️Significant reduction in plaque quantity in EPA vs placebo

#ESCCongress #EVAPORATE result being presented now! <a href="/BudoffMd/">Matthew Budoff MD</a> 
♥️Study designed to look at effect of EPA on plaque progression using CTA at baseline/9m/18m vs placebo
♥️Small study size but powered to assess endpoint
♥️Significant reduction in plaque quantity in EPA  vs placebo
Salvatore Brugaletta (@sbrugaletta) 's Twitter Profile Photo

COLCOT trial shows that early initiation of low-dose colchicine in MI reduces the risk of a composite of CV death, resuscitated cardiac arrest, MI, stroke, or urgent hospitalization for angina requiring coronary revascularization. are we ready to change guidelines? #ESCCongress

COLCOT trial shows that early initiation of low-dose colchicine in MI reduces the risk of a composite of CV death, resuscitated cardiac arrest, MI, stroke, or urgent hospitalization for angina requiring coronary revascularization. are we ready to change guidelines? #ESCCongress
Sarah Hudson (@sarahhudsonuk) 's Twitter Profile Photo

Transcatheter intervention for TR: the TRILUMINATE study of the TriClip valve showed: ▪️sustained TR reduction at 1 yr ▪️40%⬇️ in hospitalisation compared with the yr pre-device. Results discussed by Dr Von Bardeleben at #ESCCongress

Transcatheter intervention for TR: the TRILUMINATE study of the TriClip valve showed:

▪️sustained TR reduction at 1 yr
▪️40%⬇️ in hospitalisation compared with the yr pre-device. 

Results discussed by Dr Von Bardeleben at #ESCCongress
Stephan Achenbach (@steph_achenbach) 's Twitter Profile Photo

EXPLORER-HCM, hot line @ #ESCCongress 2020: Antimyosin drug mavacamten in symptomatic HOCM over 30 wks lowers gradients and achieves primary endpoint (NHYA improved and/or pVO2 up) in 37% (mavacamten) vs. 17% (placebo) Exploratory endpt.: 27% symptom-free European Society of Cardiology #cardiotwitter

John Mandrola, MD (@drjohnm) 's Twitter Profile Photo

Thread: To me, the most stunning report from #ESCCongress thus far: RATE-AF trial Older pts w/ permanent AF + shortness of breath. (there are lots of these pts). Rate control is crucial In 2020, most receive beta-blockers. But BB can cause dyspnea. What about dig? Gulp! 1/

Diego Araiza MD (@drdargaray) 's Twitter Profile Photo

2020 ESC Guidelines on NSTEACS: - 10 key concepts to remember and messages that will change our practice - #ESCCongress #ESC_Acute #Acutecvd

2020 ESC Guidelines on NSTEACS: 

- 10 key concepts to remember and messages that will change our practice - 
#ESCCongress #ESC_Acute #Acutecvd
Akanksha Thakkar (@athakkarmd) 's Twitter Profile Photo

Excited and nervous 😃 to present at Grand Rounds: ⚡️"Battling the Invisible Enemy / Radiation Safety 101: Why & How?"⚡️ 20 minutes to show #ACCFIT how to be safe in the lab with a special message for #WIC! 5/20, 8AM CST at youtube.com/watch?v=gt_o8-…

Excited and nervous 😃 to present at Grand Rounds:

⚡️"Battling the Invisible Enemy / Radiation Safety 101: Why &amp; How?"⚡️

20 minutes to show #ACCFIT how to be safe in the lab with a special message for #WIC!

5/20, 8AM CST at youtube.com/watch?v=gt_o8-…
Houston Methodist Cardiovascular Fellowships (@hmhcardiofellow) 's Twitter Profile Photo

We celebrated our 2021 Cardiology Fellowships Graduation & Awards Ceremony this past Friday. 💙🥳 Check out this special cameo from Dr. Glaucomflecken (Dr. Glaucomflecken)! ⏩vimeo.com/558073249 #hmhfellow @ACCFIT #congratsgrads #Graduation2021 Houston Methodist Residency & Fellowship Programs Houston Methodist CV